Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher
GLP-1RAs also reduce hepatic steatosis, circulating triacylglycerol, and low-density lipoprotein cholesterol concentrations and effectively reduce blood pressure [25]
Population-based cohort studies from Scandinavian registries have similarly found no association between GLP-1 agonist use and increased colorectal cancer risk
Y., Yin, H., Hillaire-Buys, D., Barkun, A., & Azoulay, L
Theres research behind this, mostly starting with animal work
This marks Teva's fifth first-to-market entry for a generic product this year, according to SVP and head of US commercial generics Ernie Richardsen